Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface

Neuroscience Research

Volumn 87, Issue C, 2014, Pages 1-7

  Saha, Nayanendu ^a   Kolev, Momchil ^a   Nikolov, Dimitar B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chondroitin sulfate; Ganglioside; LINGO 1; Myelin associated glycoprotein; Nogo receptor; NogoA

Indexed keywords

ACID PROTEIN; GANGLIOSIDE; MULTIPROTEIN COMPLEX; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; NOGO RECEPTOR; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; PROTEIN NOGO; PROTEIN NOGO A; PROTEIN P75; PROTEOCHONDROITIN SULFATE; RECEPTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LINGO1 PROTEIN, HUMAN; MAG PROTEIN, HUMAN; MEMBRANE PROTEIN; MYELIN PROTEIN; NERVE PROTEIN; OMG PROTEIN, HUMAN; PROTEIN BINDING; RTN4R PROTEIN, HUMAN; RTN4RL2 PROTEIN, HUMAN; TNFRSF19 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

CELL SURFACE; NERVE CELL; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MYELIN SHEATH; NERVE FIBER; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANIMALS; AXONS; GPI-LINKED PROTEINS; HUMANS; MEMBRANE PROTEINS; MYELIN PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; NEURONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 84925183998     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.06.003     Document Type: Review

References (46)

1. Ahmed Z., Douglas M.R., John G., Berry M., Logan A. AMIGO3 is an NgR1/p75 co-receptor signaling axon growth inhibition in the acute phase of adult central nervous system injury. PLoS ONE 2013, 8(4):e61878. 10.1371/journal.pone.0061878.
2. Barton W.A., Liu B.P., Tzvetkova D., Jeffrey P.D., Fournier A.E., Sah D., Cate R., Strittmatter S.M., Nikolov D.B. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J. 2003, 22:3291-3302.
3. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 1995, 18:223-253.
4. Collins B.E., Yang L.J., Mukhopadhyay G., Filbin M.T., Kiso M., Hasegawa A., Schnaar R.L. Sialic acid specificity of myelin-associated glycoprotein binding. J. Biol. Chem. 1997, 272:1248-1255.
5. Dickendesher T.L., Baldwin T.K., Mironova Y.A., Koriyama Y., Raiker S.J.K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y., Benowitz L.I., Geller H.M., Giger R.J. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. 2012, 15(5):703-712.
6. Domeniconi M., Cao Z., Spencer T. Myelin-associated glycoprotein interacts with nogo66 receptor to inhibit neurite outgrowth. Neuron 2002, 34:499-502.
7. Domeniconi M., Zampieri N., Spencer T., Hilaire M., Mellado W., Chao M.V., Filbin M.T. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 2005, 46:849-855.
8. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 2003, 4:703-771.
9. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal-regeneration. Nature 2003, 409:341-346.
10. García Alías G., Barkhuysen S., Buckle M., Fawcett J.W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 2009, 12:1145-1151.
11. NTR symmetrical complex. Nature 2008, 454:789-793.
12. Grandpre T., Strittmatter S.M. Nogo: a molecular determinant of axonal growth and regeneration. Neuroscientist 2001, 7(5):377-386.
13. Grünewald E., Kinnell H.L., Porteous D.J., Thomson P.A. Gpr50 interacts with neuronal NOGO-A and affects neurite outgrowth. Mol. Cell. Neurosci. 2009, 42:363-371.
14. He X.l., Bazan J.F., McDermott G., Park J.B., Wang K., Tessier-Lavigne M., He Z., Garcia K.C. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 2003, 38:177-185.
15. He X.L., Garcia K. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 305:870-875.
16. Hara-Yokoyama M., Nagatsuka Y., Katsumata O., Irie F., Kontani K., Hoshino S., Katada T., Ono Y., Fujita-Yoshigaki J., Sugiya H., Furuyama S., Hirabayashi Y. Complex gangliosides as cell surface inhibitors for the ecto-NAD+ glycohydrolase of CD38. Biochemistry 2001, 40:888-895.
17. Kajander T., Kuja-Panula J., Rauvala H., Goldman A. Crystal structure and role of glycans and dimerization in folding of neuronal leucine-rich repeat protein AMIGO. J. Mol. Biol. 2011, 413(5):1001-1015.
18. Kempf A., Tews B., Arzt M.E., Weinmann O., Obermair F.J., Pernet V., Zagrebelsky M., Delekate A., Iobbi C., Zemmar A., et al. The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. PLoS Biol. 2014, 12:e1001818.
19. Kuja-Panula J., Kiiltomaki M., Yamashiro T., Rouhiainen A., Rauvala H. AMIGO, a transmembrane protein implicated in axon tract development defines a novel protein family with leucine-rich repeats. J. Cell Biol. 2003, 160:963-973.
20. Kurihara Y., Arie Y., Iketani M., Ito H., Nishiyama K., Sato Y., Nakamura F., Mizuki N., Goshima Y., Takei K. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1. Biochem. Biophys. Res. Commun. 2012, 418:390-395.
21. Lauren J., Hu F., Chin J., Liao J., Airakinsen M.S., Strittmatter S.M. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J. Biol. Chem. 2007, 282:5715-5725.
22. Li M., Liu J., Song J. Nogo goes in the pure water: solution structure of Nogo-60 and design of the structured and buffer-soluble Nogo-54 for enhancing CNS regeneration. Protein Sci. 2006, 15(8):1835-1841.
23. Li M., Li Y., Liao X., Liu J., Qin H., Xiao Z.C., Song J. Rational design, solution conformation and identification of functional residues of the soluble and structured Nogo-54, which mimics Nogo-66 in inhibiting the CNS neurite outgrowth. Biochem. Biophys. Res. Commun. 2008, 373(4):498-503.
24. Mehta N.R., Lopez P.H., Vyas A.A., Schnaar R.L. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J. Biol. Chem. 2007, 282:27875-27886.
25. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., Crowell T., Cate R.L., McCoy J.M., Pepinsky R.B. LINGO-1 is a component of the Nogo-66 receptor/p75-signaling complex. Nat. Neurosci. 2004, 7:221-228.
26. Mosyak L., Wood A., Dwyer B., Buddha M., Johnson M., Aulabaugh A., Zhong X., Presman E., Benard S., Kelleher K., Wilhelm J., Stahl M.L., Kriz R., Gao Y., Cao Z., Ling H.P., Pangalos M.N., Walsh F.S., Somers W.S. The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition. J. Biol. Chem. 2006, 281:36378-36390.
27. Nakaya N., Sultana A., Lee H.S., Tomarev S.I. Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth. J. Biol. Chem. 2012, 287(44):37171-37184.
28. Nykjaer A., Willnow T.E., Petersen C.M. P75NTR-live or let die. Curr. Opin. Neurobiol. 2005, 15:49-57.
29. Park J.B., Yiu G., Kaneko S., Wang J., Chang J., He X.L., Garcia K.C., He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005, 45:345-351.
30. Qu Q., Chen J., Wang Y., Gui W., Wang L., Fan Z., Jiang T. Structural characterization of the self-association of the death domain of p75 (NTR). PLoS ONE 2013, 8(3):e57839.
31. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204:33-48.
32. Robak L.A., Venkatesh K., Lee H., Raiker S.J., Duan Y., Lee-Osbourne J., Hofer T., Mage R.G., Rader C., Giger R.J. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNi-Fc a novel antagonist of CNS myelin inhibition. J. Neurosci. 2009, 29:5768-5783.
33. Saha N., Kolev M.V., Semavina M., Himanen J., Nikolov D.B. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1. Biochem. Biophys. Res. Commun. 2011, 413:92-97.
34. Sato Y., Iketani M., Kurihara Y., Yamaguchi M., Yamashita N., Nakamura F., Arie Y., Kawasaki T., Hirata T., Abe T., Kiyonari H., Strittmatter S.M., Goshima Y., Takei K. Cartilage acidic protein-1B/LOTUS, an endogenous Nogo receptor antagonist serving for axon tract formation. Science 2011, 333:769-773.
35. Semavina M., Saha N., Kolev M.V., Goldgur Y., Giger R.J., Himanen J.P., Nikolov D.B. Crystal structure of the Nogo-receptor-2. Protein Sci. 2011, 20(4):684-689.
36. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPσ is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
37. Shi J., Longo F.M., Massa S.M. A small molecule p75NTR ligand protects neurogenesis after traumatic brain injury. Stem Cells 2013, 31:2561-2574.
38. Spiro R.G. Glycoproteins. Adv. Protein Chem. 1973, 27:349-467.
39. Steck E., Bräun J., Pelttari K., Kadel S., Kalbacher H., Richter W. Chondrocyte secreted CRTAC1: a glycosylated extracellular matrix molecule of human articular cartilage. Matrix Biol. 2007, 26:30-41.
40. Tang S., Sheen Y.J., DeBellard M.E., Mukhopadhyay G., Salzer J.L., Crocker P.R., Filbin M.T. Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J. Cell Biol. 1997, 138:1355-1366.
41. Tomarev S.I., Nakaya N. Olfactomedin domain-containing proteins. Possible mechanisms of action and functions in normal development and pathology. Mol. Neurobiol. 2009, 40:122-138.
42. Vasudevan V.S., Schulz J., Zhou C., Cocco M.J. Protein folding at the membrane interface, the structure of Nogo-66 requires interactions with a phosphocholine surface. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6847-6851.
43. Venkatesh K., Chivatakarn O., Lee H., Joshi P.S., Kantor D.B., Newman B.A., Mage R., Rader C., Giger R.J. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 2005, 25:808-822.
44. Walmsley A.R., Mir A.K. Targeting the Nogo-A signaling pathway to promote recovery following acute CNS injury. Curr. Pharm. Des. 2007, 13:2470-2484.
45. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002, 417:941-944.
46. Williams G., Wood A., Williams E.J., Gao Y., Mercado M.L., Katz A., Joseph-McCarthy D., Bates B., Ling H.P., Aulabaugh A., Zaccardi J., Xie Y., Pangalos M.N., Walsh F.S., Doherty P. Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists. J. Biol. Chem. 2008, 283:16641-16652.